Viamet Pharmaceuticals, Inc.

Release Summary

Viamet Presents Positive Results from Phase 2b Trial of VT-1161 in Onychomycosis at American Academy of Dermatology Annual Meeting. Results demonstrate robust efficacy and favorable safety profile.

Viamet Pharmaceuticals, Inc.